Sight Sciences, Inc. (SGHT)
NASDAQ · Healthcare
Sight Sciences, Inc. EBITDA 2020–2025
Sight Sciences, Inc. annual/quarterly ebitda history and growth rate from 2023 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Sight Sciences, Inc. ebitda for the quarter ending March 31, 2026 was -12.3 M, a 10.21% decrease year-over-year.
- Sight Sciences, Inc. ebitda for the twelve months ending March 31, 2026 was -58.0 M.
- Sight Sciences, Inc. annual ebitda for 2025 was -36.6 M, a 26.51% decrease from 2024.
- Sight Sciences, Inc. annual ebitda for 2024 was -49.8 M, a 12.07% decrease from 2023.
- Sight Sciences, Inc. annual ebitda for 2023 was -56.7 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sight Sciences, Inc. EBITDA — FAQ
Sight Sciences, Inc. (SGHT) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SGHT's ebitda history?
The chart and table above show Sight Sciences, Inc.'s ebitda by year and by quarter, including the growth rate.